Skip to main content
Premium Trial:

Request an Annual Quote

Eleven Therapeutics: Yaniv Erlich

Yaniv Erlich has joined Eleven Therapeutics, a startup he cofounded that has locations in the UK and Israel, as CEO and CSO. He retains his post as CSO of MyHeritage. Previously, he was an associate professor of computer science and computational biology at Columbia University and a core member of the New York Genome Center.

The Scan

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.